H. Edward Fleming, Jr., M.D.

H. Edward Fleming, Jr., M.D.

DirectoratUpstream Bio· In proxies 2023–2025

H. Edward Fleming, Jr., M.D. sits on 4 public boards.

Boards1

  • CRISPR Therapeutics AGDirector · 2 yr on the boardIndependentDirectors and Executive—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Upstream BioPublic company · 1 yr
    • Director2025 – Present · 1 yrStock in role -85%
  2. CRISPR Therapeutics AGPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Sionna Therapeutics, Inc.Public company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  4. Upstream Bio, Inc.Public company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?